Smartleaf Asset Management LLC grew its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 24.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,434 shares of the semiconductor company's stock after acquiring an additional 4,376 shares during the quarter. Smartleaf Asset Management LLC's holdings in Lam Research were worth $1,629,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Smallwood Wealth Investment Management LLC purchased a new position in shares of Lam Research in the 1st quarter valued at $26,000. West Paces Advisors Inc. purchased a new position in shares of Lam Research in the 4th quarter valued at $27,000. Mpwm Advisory Solutions LLC purchased a new position in shares of Lam Research in the 4th quarter valued at $27,000. Park Square Financial Group LLC purchased a new position in shares of Lam Research in the 4th quarter valued at $31,000. Finally, Putney Financial Group LLC purchased a new position in shares of Lam Research in the 4th quarter valued at $36,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.
Lam Research Stock Up 1.7%
Lam Research stock opened at $100.08 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. The business's 50-day simple moving average is $98.41 and its two-hundred day simple moving average is $84.61. The company has a market cap of $126.66 billion, a PE ratio of 24.06, a PEG ratio of 1.30 and a beta of 1.65. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $108.02.
Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.12. The business had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company's quarterly revenue was up 33.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on LRCX shares. Oppenheimer lifted their price target on Lam Research from $110.00 to $120.00 and gave the company an "outperform" rating in a report on Thursday, July 31st. The Goldman Sachs Group started coverage on Lam Research in a research note on Thursday, July 10th. They set a "buy" rating and a $115.00 target price on the stock. UBS Group boosted their target price on Lam Research from $95.00 to $120.00 and gave the stock a "buy" rating in a research note on Monday, July 21st. Mizuho boosted their target price on Lam Research from $115.00 to $120.00 and gave the stock an "outperform" rating in a research note on Friday, August 1st. Finally, Summit Insights downgraded Lam Research from a "buy" rating to a "hold" rating in a research note on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $107.30.
Read Our Latest Analysis on Lam Research
About Lam Research
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.